Revenue Summary of Beijing Science Sun Pharmaceutical Co., Ltd.

Beijing Science Sun Pharmaceutical Co., Ltd.'s latest annual revenue in 2023 was 476.56 Million CNY , down -35.12% from previous year.
Beijing Science Sun Pharmaceutical Co., Ltd.'s latest quarterly revenue in 2024 Q3 was 108.04 Million CNY , up 2.6% from previous quarter.
Beijing Science Sun Pharmaceutical Co., Ltd. reported a annual revenue of 734.54 Million CNY in annual revenue 2022, down -30.1% from previous year.
Beijing Science Sun Pharmaceutical Co., Ltd. reported a annual revenue of 1.05 Billion CNY in annual revenue 2021, down -3.97% from previous year.
Beijing Science Sun Pharmaceutical Co., Ltd. reported a quarterly revenue of 105.3 Million CNY for 2024 Q2, down -3.24% from previous quarter.
Beijing Science Sun Pharmaceutical Co., Ltd. reported a quarterly revenue of 108.82 Million CNY for 2024 Q1, up 31.52% from previous quarter.

Annual Revenue Chart of Beijing Science Sun Pharmaceutical Co., Ltd. (2023 - 2011)

Historical Annual Revenue of Beijing Science Sun Pharmaceutical Co., Ltd. (2023 - 2011)

Year	Revenue	Revenue Growth
2023	476.56 Million CNY	-35.12%
2022	734.54 Million CNY	-30.1%
2021	1.05 Billion CNY	-3.97%
2020	1.09 Billion CNY	-8.12%
2019	1.19 Billion CNY	-16.59%
2018	1.42 Billion CNY	90.37%
2017	749.98 Million CNY	21.7%
2016	616.23 Million CNY	1.5%
2015	607.13 Million CNY	2.93%
2014	589.84 Million CNY	22.83%
2013	480.21 Million CNY	21.26%
2012	396.01 Million CNY	61.62%
2011	245.02 Million CNY	0.0%

Year	Revenue	Revenue Growth
2024 Q3	108.04 Million CNY	2.6%
2024 Q2	105.3 Million CNY	-3.24%
2024 Q1	108.82 Million CNY	31.52%
2023 Q3	121.78 Million CNY	-12.6%
2023 Q4	82.74 Million CNY	-32.06%
2023 FY	476.56 Million CNY	-35.12%
2023 Q1	132.69 Million CNY	-1.93%
2023 Q2	139.33 Million CNY	5.0%
2022 FY	734.54 Million CNY	-30.1%
2022 Q2	191.24 Million CNY	-0.44%
2022 Q1	192.09 Million CNY	-20.4%
2022 Q4	135.31 Million CNY	-37.32%
2022 Q3	215.89 Million CNY	12.89%
2021 Q2	288.79 Million CNY	23.88%
2021 Q4	241.32 Million CNY	-16.07%
2021 Q1	233.13 Million CNY	-23.05%
2021 FY	1.05 Billion CNY	-3.97%
2021 Q3	287.54 Million CNY	-0.43%
2020 Q1	167.24 Million CNY	-46.41%
2020 FY	1.09 Billion CNY	-8.12%
2020 Q4	302.96 Million CNY	-1.23%
2020 Q3	306.73 Million CNY	-3.32%
2020 Q2	317.27 Million CNY	89.7%
2019 FY	1.19 Billion CNY	-16.59%
2019 Q4	312.06 Million CNY	-9.18%
2019 Q3	343.59 Million CNY	1.04%
2019 Q2	340.04 Million CNY	74.2%
2019 Q1	195.2 Million CNY	-60.0%
2018 FY	1.42 Billion CNY	90.37%
2018 Q4	488.06 Million CNY	33.15%
2018 Q3	366.54 Million CNY	21.1%
2018 Q2	302.67 Million CNY	11.9%
2018 Q1	270.47 Million CNY	1.75%
2017 Q1	108.2 Million CNY	-26.48%
2017 FY	749.98 Million CNY	21.7%
2017 Q3	220.06 Million CNY	41.16%
2017 Q4	265.82 Million CNY	20.79%
2017 Q2	155.89 Million CNY	44.08%
2016 Q3	165.14 Million CNY	-1.13%
2016 Q2	167.04 Million CNY	22.04%
2016 Q1	136.87 Million CNY	-9.07%
2016 FY	616.23 Million CNY	1.5%
2016 Q4	147.17 Million CNY	-10.88%
2015 Q2	158.54 Million CNY	19.83%
2015 FY	607.13 Million CNY	2.93%
2015 Q4	150.53 Million CNY	-9.18%
2015 Q3	165.74 Million CNY	4.55%
2015 Q1	132.31 Million CNY	-11.54%
2014 Q1	117.44 Million CNY	0.0%
2014 Q2	156.51 Million CNY	33.27%
2014 Q4	149.57 Million CNY	-10.06%
2014 FY	589.84 Million CNY	22.83%
2014 Q3	166.3 Million CNY	6.26%
2013 FY	480.21 Million CNY	21.26%
2012 FY	396.01 Million CNY	61.62%
2011 FY	245.02 Million CNY	0.0%

Peer Revenue Comparison of Beijing Science Sun Pharmaceutical Co., Ltd.

Name	Revenue	Revenue Difference
Shenzhen Kangtai Biological Products Co., Ltd.	3.47 Billion CNY	86.295%
PharmaBlock Sciences (Nanjing), Inc.	1.72 Billion CNY	72.376%
Shandong Shanda Wit Science and Technology Co., Ltd.	2.48 Billion CNY	80.816%
Pacific Shuanglin Bio-pharmacy Co., LTD	2.32 Billion CNY	79.535%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	1.46 Billion CNY	67.418%
Jilin Aodong Pharmaceutical Group Co., Ltd.	3.44 Billion CNY	86.183%
Chengdu Huasun Technology Group Inc., Ltd.	1 Billion CNY	52.503%
Zhejiang AngLiKang Pharmaceutical CO.,LTD.	1.62 Billion CNY	70.688%
Hengkang Medical Group Co., Ltd.	3.59 Billion CNY	86.727%
Anhui Huangshan Capsule Co., Ltd.	458.36 Million CNY	-3.971%
Walvax Biotechnology Co., Ltd.	4.11 Billion CNY	88.415%
Tianjin Ringpu Bio-Technology Co.,Ltd.	2.24 Billion CNY	78.809%
Anhui Fengyuan Pharmaceutical Co., Ltd.	4.27 Billion CNY	88.853%
Apeloa Pharmaceutical Co.,Ltd	11.47 Billion CNY	95.847%
Harbin Gloria Pharmaceuticals Co., Ltd	2.58 Billion CNY	81.599%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.	24.73 Billion CNY	98.074%
Hunan Hansen Pharmaceutical Co., Ltd.	955.53 Million CNY	50.125%
Xiamen Kingdomway Group Company	3.1 Billion CNY	84.64%
Zhejiang Tianyu Pharmaceutical Co., Ltd.	2.52 Billion CNY	81.143%
Zhuhai Rundu Pharmaceutical Co., Ltd.	1.29 Billion CNY	63.111%
Hainan Haiyao Co., Ltd.	1.45 Billion CNY	67.296%
Shenzhen Neptunus Bioengineering Co., Ltd.	36.41 Billion CNY	98.691%
Fujian Cosunter Pharmaceutical Co., Ltd.	422.71 Million CNY	-12.74%
Huapont Life Sciences Co., Ltd.	11.59 Billion CNY	95.89%
Livzon Pharmaceutical Group Inc.	12.27 Billion CNY	96.119%
Honz Pharmaceutical Co., Ltd.	739.56 Million CNY	35.561%
Northeast Pharmaceutical Group Co., Ltd.	8.16 Billion CNY	94.161%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	5.42 Billion CNY	91.21%
Hainan Poly Pharm. Co., Ltd	1.3 Billion CNY	63.467%
Sunflower Pharmaceutical Group Co.,Ltd	5.63 Billion CNY	91.538%
Zhejiang Jingxin Pharmaceutical Co., Ltd.	3.95 Billion CNY	87.941%
Kunming Longjin Pharmaceutical Co., Ltd.	86.62 Million CNY	-450.168%
Zhejiang Hisoar Pharmaceutical Co., Ltd.	2.17 Billion CNY	78.057%
Zhejiang Yatai Pharmaceutical Co., Ltd.	420.64 Million CNY	-13.295%
Zhejiang NHU Company Ltd.	15.11 Billion CNY	96.847%
Zhejiang Xinguang Pharmaceutical Co., Ltd.	270.39 Million CNY	-76.246%
Jiuzhitang Co., Ltd.	2.91 Billion CNY	83.675%
Qianjiang Yongan Pharmaceutical Co., Ltd.	962.8 Million CNY	50.502%
Jinghua Pharmaceutical Group Co., Ltd.	1.49 Billion CNY	68.025%
Hunan Er-Kang Pharmaceutical Co., Ltd	1.76 Billion CNY	73.063%
Yunnan Baiyao Group Co.,Ltd	38.9 Billion CNY	98.775%
ApicHope Pharmaceutical Co., Ltd	2.5 Billion CNY	80.963%
Shandong Wohua Pharmaceutical Co., Ltd.	894.31 Million CNY	46.711%
Jinling Pharmaceutical Company Limited	2.78 Billion CNY	82.893%
Beijing SL Pharmaceutical Co., Ltd.	1.01 Billion CNY	53.202%
Shanxi Zhendong Pharmaceutical Co.,Ltd	3.62 Billion CNY	86.857%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd	980.82 Million CNY	51.412%
Huaren Pharmaceutical Co., Ltd.	1.63 Billion CNY	70.874%
Betta Pharmaceuticals Co., Ltd.	2.45 Billion CNY	80.597%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD	1.08 Billion CNY	55.875%
Changzhou Qianhong Biopharma CO.,LTD	1.79 Billion CNY	73.433%
Chengdu Kanghong Pharmaceutical Group Co., Ltd	3.95 Billion CNY	87.958%
Changjiang Pharmaceutical Group Co., Ltd.	1.19 Billion CNY	60.205%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.	839.25 Million CNY	43.215%
Zhejiang Garden Bio-chemical High-tech Co., Ltd.	1.09 Billion CNY	56.464%
Tianjin Lisheng Pharmaceutical Co.,Ltd.	1.13 Billion CNY	57.832%
Guangdong Lifestrong Pharmacy Co., Ltd.	292.39 Million CNY	-62.987%
Huadong Medicine Co., Ltd	40.39 Billion CNY	98.82%
PKU HealthCare Corp.,Ltd.	2.19 Billion CNY	78.276%
Hybio Pharmaceutical Co., Ltd.	431.38 Million CNY	-10.475%
Shenzhen Weiguang Biological Products Co., Ltd.	1.04 Billion CNY	54.548%
Fuan Pharmaceutical (Group) Co., Ltd.	2.64 Billion CNY	82.001%
Jiangsu Nhwa Pharmaceutical Co., LTD	4.97 Billion CNY	90.418%
Harbin Medisan Pharmaceutical Co., Ltd.	1.18 Billion CNY	59.844%
Teyi Pharmaceutical Group Co.,Ltd	1.06 Billion CNY	55.344%
Tus-Pharmaceutical Group Co., Ltd.	395.92 Million CNY	-20.369%
LanZhou Foci Pharmaceutical Co.,Ltd.	1.16 Billion CNY	59.027%
Changchun High-Tech Industries (Group) Inc.	14.46 Billion CNY	96.704%
Shanghai Kaibao Pharmaceutical CO.,Ltd	1.59 Billion CNY	70.103%
Shandong Xinhua Pharmaceutical Company Limited	8 Billion CNY	94.049%
Beijing Beilu Pharmaceutical Co., Ltd	890.71 Million CNY	46.496%
Dezhan Healthcare Company Limited	498.08 Million CNY	4.32%
Tianjin Chase Sun Pharmaceutical Co.,Ltd	6.12 Billion CNY	92.222%
Beijing Aosaikang Pharmaceutical Co., Ltd.	1.44 Billion CNY	66.984%
Jinhe Biotechnology CO., LTD.	2.17 Billion CNY	78.08%
Baotou Dongbao Bio-Tech Co.,Ltd	974.51 Million CNY	51.097%
ShanXi C&Y Pharmaceutical Group Co., Ltd.	799.3 Million CNY	40.377%
Tibet AIM Pharm. Inc.	667.03 Million CNY	28.554%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.	2.61 Billion CNY	81.744%
Nanjing Hicin Pharmaceutical Co., Ltd.	517.83 Million CNY	7.968%
Renhe Pharmacy Co., Ltd.	5.03 Billion CNY	90.529%
Wuhan Hiteck Biological Pharma Co.,Ltd	602.28 Million CNY	20.873%
Guizhou Xinbang Pharmaceutical Co., Ltd.	6.46 Billion CNY	92.624%
Dong-E-E-Jiao Co.,Ltd.	4.71 Billion CNY	89.893%
Jiangxi Synergy Pharmaceutical Co., Ltd.	722.13 Million CNY	34.006%
Chongqing Pharscin Pharmaceutical Co., Ltd.	691.54 Million CNY	31.086%
Zhejiang Xianju Pharmaceutical Co.,Ltd.	4.12 Billion CNY	88.442%
Luoxin Pharmaceuticals Group Stock Co., Ltd.	2.34 Billion CNY	79.657%
Guizhou Bailing Group Pharmaceutical Co., Ltd.	4.26 Billion CNY	88.821%

Global Stocks Search

Beijing Science Sun Pharmaceutical Co., Ltd. (300485.SZ)

Revenue Summary of Beijing Science Sun Pharmaceutical Co., Ltd.

Annual Revenue Chart of Beijing Science Sun Pharmaceutical Co., Ltd. (2023 - 2011)

Historical Annual Revenue of Beijing Science Sun Pharmaceutical Co., Ltd. (2023 - 2011)

Peer Revenue Comparison of Beijing Science Sun Pharmaceutical Co., Ltd.